Amdocs (DOX) Stock Forecast, Price Target & Predictions
DOX Stock Forecast
Amdocs stock forecast is as follows: an average price target of $96.60 (represents a 9.14% upside from DOX’s last price of $88.51) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
DOX Price Target
The average price target for Amdocs (DOX) is $96.60 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $100.00 to $90.00. This represents a potential 9.14% upside from DOX's last price of $88.51.
DOX Analyst Ratings
According to 3 Wall Street analysts, Amdocs's rating consensus is 'Buy'. The analyst rating breakdown for DOX stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Amdocs Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 01, 2024 | Tom Roderick | Stifel Nicolaus | $100.00 | $87.38 | 14.44% | 12.98% |
| May 09, 2024 | William Power | Robert W. Baird | $90.00 | $85.91 | 4.76% | 1.68% |
| Feb 01, 2023 | - | Oppenheimer | $99.00 | $91.93 | 7.69% | 11.85% |
| Aug 04, 2022 | - | Barclays | $95.00 | $85.72 | 10.83% | 7.33% |
| Aug 04, 2022 | - | Citigroup | $99.00 | $85.72 | 15.49% | 11.85% |
The latest Amdocs stock forecast, released on Oct 01, 2024 by Tom Roderick from Stifel Nicolaus, set a price target of $100.00, which represents a 14.44% increase from the stock price at the time of the forecast ($87.38), and a 12.98% increase from DOX last price ($88.51).
Amdocs Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 2 |
| Avg Price Target | - | $100.00 | $95.00 |
| Last Closing Price | $88.51 | $88.51 | $88.51 |
| Upside/Downside | -100.00% | 12.98% | 7.33% |
In the current month, the average price target of Amdocs stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Amdocs's last price of $88.51. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 09, 2024 | Citigroup | Buy | Buy | Hold |
| May 16, 2023 | Barclays | Equal-Weight | Overweight | Upgrade |
| Feb 01, 2023 | Oppenheimer | Outperform | Outperform | Hold |
| Aug 04, 2022 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Aug 04, 2022 | Citigroup | Buy | Buy | Hold |
Amdocs's last stock rating was published by Citigroup on May 09, 2024. The company gave DOX a "Buy" rating, the same as its previous rate.
Amdocs Financial Forecast
Amdocs Revenue Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.22B | $1.19B | $1.17B | $1.16B | $1.15B | $1.10B | $1.09B | $1.07B | $1.05B | $1.09B | $1.05B | $1.03B | $1.05B | $1.04B | $1.03B | $1.02B |
| Avg Forecast | $1.35B | $1.33B | $1.32B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.26B | $1.25B | $1.25B | $1.24B | $1.24B | $1.24B | $1.22B | $1.18B | $1.17B | $1.16B | $1.13B | $1.10B | $1.09B | $1.06B | $1.04B | $1.08B | $1.03B | $1.01B | $1.04B | $1.03B | $1.03B | $1.03B |
| High Forecast | $1.35B | $1.33B | $1.32B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.27B | $1.25B | $1.25B | $1.25B | $1.24B | $1.24B | $1.22B | $1.18B | $1.17B | $1.16B | $1.13B | $1.10B | $1.09B | $1.06B | $1.04B | $1.08B | $1.03B | $1.01B | $1.04B | $1.03B | $1.03B | $1.03B |
| Low Forecast | $1.35B | $1.33B | $1.32B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.25B | $1.25B | $1.25B | $1.23B | $1.24B | $1.24B | $1.22B | $1.18B | $1.17B | $1.16B | $1.13B | $1.10B | $1.09B | $1.06B | $1.04B | $1.08B | $1.03B | $1.01B | $1.04B | $1.03B | $1.03B | $1.03B |
| # Analysts | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.00% | 1.00% | 1.00% | 1.02% | 1.00% | 1.00% | 1.00% | 1.01% | 1.01% | 1.02% | 1.01% | 1.00% | 1.01% | 1.00% | 1.00% |
Amdocs's average Quarter revenue forecast for Jun 23 based on 2 analysts is $1.24B, with a low forecast of $1.24B, and a high forecast of $1.24B. DOX's average Quarter revenue forecast represents a 1.02% increase compared to the company's last Quarter revenue of $1.22B (Mar 23).
Amdocs EBITDA Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $224.29M | $235.68M | $189.52M | $242.96M | $213.85M | $218.46M | $205.04M | $210.98M | $198.84M | $418.32M | $199.62M | $194.14M | $205.82M | $192.58M | $196.72M | $195.72M |
| Avg Forecast | $242.91M | $238.92M | $236.49M | $238.77M | $235.92M | $234.10M | $231.36M | $229.60M | $226.90M | $225.42M | $198.72M | $223.43M | $222.96M | $221.99M | $180.66M | $236.23M | $209.32M | $208.39M | $164.23M | $197.66M | $196.30M | $190.64M | $198.84M | $193.36M | $185.69M | $181.66M | $201.94M | $185.60M | $185.35M | $184.15M |
| High Forecast | $242.91M | $238.92M | $236.49M | $238.77M | $235.92M | $234.10M | $231.36M | $229.60M | $228.68M | $225.42M | $238.47M | $225.22M | $223.51M | $221.99M | $216.79M | $283.48M | $209.32M | $208.39M | $197.08M | $197.66M | $196.30M | $190.64M | $238.60M | $193.36M | $185.69M | $181.66M | $242.32M | $185.60M | $185.35M | $184.15M |
| Low Forecast | $242.91M | $238.92M | $236.49M | $238.77M | $235.92M | $234.10M | $231.36M | $229.60M | $225.11M | $225.42M | $158.98M | $221.65M | $222.68M | $221.99M | $144.53M | $188.99M | $209.32M | $208.39M | $131.39M | $197.66M | $196.30M | $190.64M | $159.07M | $193.36M | $185.69M | $181.66M | $161.55M | $185.60M | $185.35M | $184.15M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.24% | 1.00% | 0.91% | 1.17% | 1.30% | 1.11% | 1.04% | 1.11% | 1.00% | 2.16% | 1.08% | 1.07% | 1.02% | 1.04% | 1.06% | 1.06% |
2 analysts predict DOX's average Quarter EBITDA for Jun 23 to be $221.99M, with a high of $221.99M and a low of $221.99M. This is -1.03% lower than Amdocs's previous annual EBITDA (Mar 23) of $224.29M.
Amdocs Net Income Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $149.60M | $129.67M | $128.94M | $128.47M | $158.50M | $133.60M | $123.53M | $146.15M | $119.07M | $299.63M | $134.46M | $120.41M | $127.04M | $115.93M | $122.03M | $131.45M |
| Avg Forecast | $233.41M | $224.16M | $216.07M | $218.96M | $212.61M | $205.39M | $199.90M | $196.43M | $196.31M | $185.22M | $147.29M | $180.68M | $163.71M | $170.99M | $133.90M | $144.47M | $149.10M | $146.30M | $121.73M | $136.81M | $135.96M | $139.04M | $119.07M | $132.47M | $136.93M | $121.18M | $124.64M | $121.71M | $124.42M | $128.55M |
| High Forecast | $233.41M | $224.16M | $216.07M | $218.96M | $212.61M | $205.39M | $199.90M | $196.43M | $196.31M | $185.22M | $176.75M | $181.83M | $163.71M | $170.99M | $160.68M | $173.37M | $150.19M | $152.75M | $146.07M | $136.81M | $139.93M | $139.04M | $142.88M | $132.47M | $136.93M | $121.18M | $149.57M | $121.71M | $124.42M | $128.55M |
| Low Forecast | $233.41M | $224.16M | $216.07M | $218.96M | $212.61M | $205.39M | $199.90M | $196.43M | $195.16M | $185.21M | $117.83M | $179.53M | $162.56M | $170.99M | $107.12M | $115.58M | $148.02M | $139.86M | $97.38M | $136.81M | $132.00M | $139.04M | $95.25M | $132.47M | $136.93M | $121.18M | $99.71M | $121.71M | $124.42M | $128.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.12% | 0.90% | 0.86% | 0.88% | 1.30% | 0.98% | 0.91% | 1.05% | 1.00% | 2.26% | 0.98% | 0.99% | 1.02% | 0.95% | 0.98% | 1.02% |
Amdocs's average Quarter net income forecast for Jun 23 is $170.99M, with a range of $170.99M to $170.99M. DOX's average Quarter net income forecast represents a 14.29% increase compared to the company's last Quarter net income of $149.60M (Mar 23).
Amdocs SG&A Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $143.33M | $143.22M | $129.40M | $136.11M | $134.98M | $128.08M | $126.02M | $122.40M | $116.95M | $121.89M | $106.35M | $109.61M | $119.11M | $123.47M | $125.05M | $125.09M |
| Avg Forecast | $155.87M | $153.31M | $151.76M | $153.22M | $151.39M | $150.22M | $148.46M | $147.33M | $145.60M | $144.65M | $125.44M | $143.38M | $143.07M | $142.45M | $114.03M | $138.50M | $134.32M | $133.72M | $103.67M | $126.84M | $125.96M | $122.33M | $116.95M | $124.08M | $119.16M | $116.57M | $116.86M | $119.10M | $118.94M | $118.17M |
| High Forecast | $155.87M | $153.31M | $151.76M | $153.22M | $151.39M | $150.22M | $148.46M | $147.33M | $146.75M | $144.65M | $150.52M | $144.52M | $143.42M | $142.45M | $136.84M | $166.19M | $134.32M | $133.72M | $124.40M | $126.84M | $125.96M | $122.33M | $140.34M | $124.08M | $119.16M | $116.57M | $140.23M | $119.10M | $118.94M | $118.17M |
| Low Forecast | $155.87M | $153.31M | $151.76M | $153.22M | $151.39M | $150.22M | $148.46M | $147.33M | $144.45M | $144.65M | $100.35M | $142.23M | $142.89M | $142.45M | $91.23M | $110.80M | $134.32M | $133.72M | $82.93M | $126.84M | $125.96M | $122.33M | $93.56M | $124.08M | $119.16M | $116.57M | $93.49M | $119.10M | $118.94M | $118.17M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.26% | 1.03% | 0.96% | 1.02% | 1.30% | 1.01% | 1.00% | 1.00% | 1.00% | 0.98% | 0.89% | 0.94% | 1.02% | 1.04% | 1.05% | 1.06% |
Amdocs's average Quarter SG&A projection for Jun 23 is $142.45M, based on 2 Wall Street analysts, with a range of $142.45M to $142.45M. The forecast indicates a -0.61% fall compared to DOX last annual SG&A of $143.33M (Mar 23).
Amdocs EPS Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.24 | $1.07 | $1.06 | $1.05 | $1.29 | $1.09 | $0.98 | $1.15 | $0.92 | $2.29 | $1.02 | $0.90 | $0.95 | $0.86 | $0.90 | $0.96 |
| Avg Forecast | $2.02 | $1.94 | $1.87 | $1.90 | $1.84 | $1.78 | $1.73 | $1.70 | $1.70 | $1.60 | $1.57 | $1.56 | $1.42 | $1.48 | $1.47 | $1.34 | $1.29 | $1.27 | $1.25 | $1.18 | $1.18 | $1.20 | $1.13 | $1.15 | $1.19 | $1.05 | $1.06 | $1.05 | $1.08 | $1.11 |
| High Forecast | $2.02 | $1.94 | $1.87 | $1.90 | $1.84 | $1.78 | $1.73 | $1.70 | $1.70 | $1.60 | $1.58 | $1.57 | $1.42 | $1.48 | $1.49 | $1.34 | $1.30 | $1.32 | $1.25 | $1.18 | $1.21 | $1.20 | $1.13 | $1.15 | $1.19 | $1.05 | $1.06 | $1.05 | $1.08 | $1.11 |
| Low Forecast | $2.02 | $1.94 | $1.87 | $1.90 | $1.84 | $1.78 | $1.73 | $1.70 | $1.69 | $1.60 | $1.57 | $1.55 | $1.41 | $1.48 | $1.45 | $1.34 | $1.28 | $1.21 | $1.25 | $1.18 | $1.14 | $1.20 | $1.13 | $1.15 | $1.19 | $1.05 | $1.06 | $1.05 | $1.08 | $1.11 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.84% | 0.80% | 0.82% | 0.83% | 1.03% | 0.92% | 0.83% | 0.96% | 0.81% | 2.00% | 0.86% | 0.86% | 0.89% | 0.82% | 0.84% | 0.86% |
According to 2 Wall Street analysts, Amdocs's projected average Quarter EPS for Jun 23 is $1.48, with a low estimate of $1.48 and a high estimate of $1.48. This represents a 19.34% increase compared to DOX previous annual EPS of $1.24 (Mar 23).
Amdocs Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| VRSN | VeriSign | $177.86 | $240.00 | 34.94% | Buy |
| WEX | WEX | $172.05 | $219.83 | 27.77% | Hold |
| AKAM | Akamai | $100.04 | $119.71 | 19.66% | Buy |
| QLYS | Qualys | $124.60 | $147.25 | 18.18% | Buy |
| DOX | Amdocs | $88.48 | $96.60 | 9.18% | Buy |
| CSGS | CSG Systems | $47.66 | $52.00 | 9.11% | Buy |
| CCSI | Consensus Cloud Solutions | $23.57 | $25.00 | 6.07% | Buy |
| FLT | Corpay | $303.26 | $296.71 | -2.16% | Buy |
| FFIV | F5 | $231.20 | $224.44 | -2.92% | Hold |
| CHKP | Check Point Software | $170.18 | $160.08 | -5.93% | Buy |
| CYBR | CyberArk Software | $274.10 | $256.69 | -6.35% | Buy |
| EVTC | EVERTEC | $33.02 | $28.00 | -15.20% | Sell |
DOX Forecast FAQ
Is Amdocs a good buy?
Yes, according to 3 Wall Street analysts, Amdocs (DOX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of DOX's total ratings.
What is DOX's price target?
Amdocs (DOX) average price target is $96.6 with a range of $90 to $100, implying a 9.14% from its last price of $88.51. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Amdocs stock go up soon?
According to Wall Street analysts' prediction for DOX stock, the company can go up by 9.14% (from the last price of $88.51 to the average price target of $96.6), up by 12.98% based on the highest stock price target, and up by 1.68% based on the lowest stock price target.
Can Amdocs stock reach $130?
DOX's average twelve months analyst stock price target of $96.6 does not support the claim that Amdocs can reach $130 in the near future.
What are Amdocs's analysts' financial forecasts?
Amdocs's analysts financial forecasts for the fiscal year (Sep 2025) are as follows: average revenue is $5.18B (high $5.18B, low $5.18B), average EBITDA is $930.98M (high $930.98M, low $930.98M), average net income is $814.32M (high $814.32M, low $814.32M), average SG&A $597.41M (high $597.41M, low $597.41M), and average EPS is $7.05 (high $7.05, low $7.05). DOX's analysts financial forecasts for the fiscal year (Sep 2026) are as follows: average revenue is $5.33B (high $5.33B, low $5.33B), average EBITDA is $957.09M (high $957.09M, low $957.09M), average net income is $892.61M (high $892.61M, low $892.61M), average SG&A $614.16M (high $614.16M, low $614.16M), and average EPS is $7.72 (high $7.72, low $7.72).
Did the DOX's actual financial results beat the analysts' financial forecasts?
Based on Amdocs's last annual report (Sep 2022), the company's revenue was $4.58B, beating the average analysts forecast of $4.55B by 0.53%. Apple's EBITDA was $889.33M, beating the average prediction of $779.6M by 14.08%. The company's net income was $549.5M, missing the average estimation of $553.94M by -0.80%. Apple's SG&A was $528.57M, beating the average forecast of $498.54M by 6.02%. Lastly, the company's EPS was $4.47, missing the average prediction of $4.99 by -10.41%. In terms of the last quarterly report (Mar 2023), Amdocs's revenue was $1.22B, beating the average analysts' forecast of $1.22B by 0.34%. The company's EBITDA was $224.29M, beating the average prediction of $180.66M by 24.15%. Amdocs's net income was $149.6M, beating the average estimation of $133.9M by 11.73%. The company's SG&A was $143.33M, beating the average forecast of $114.03M by 25.69%. Lastly, the company's EPS was $1.24, missing the average prediction of $1.47 by -15.65%